AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 49 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 48 | -99.9% | 0.00% | -100.0% |
Q2 2023 | $813 | -18.7% | 49,335 | +31935.7% | 0.00% | – |
Q3 2021 | $1,000 | -75.0% | 154 | -78.2% | 0.00% | – |
Q2 2021 | $4,000 | -96.9% | 708 | -95.0% | 0.00% | – |
Q1 2021 | $130,000 | +36.8% | 14,303 | +0.6% | 0.00% | – |
Q4 2020 | $95,000 | +33.8% | 14,215 | +1.4% | 0.00% | – |
Q3 2020 | $71,000 | -78.4% | 14,015 | -65.5% | 0.00% | – |
Q2 2020 | $328,000 | +195.5% | 40,615 | +189.1% | 0.00% | – |
Q1 2020 | $111,000 | – | 14,049 | +200600.0% | 0.00% | – |
Q1 2019 | $0 | – | 7 | -90.8% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 76 | -65.6% | 0.00% | – |
Q3 2018 | $1,000 | -88.9% | 221 | -85.5% | 0.00% | – |
Q2 2018 | $9,000 | -83.0% | 1,521 | -79.4% | 0.00% | – |
Q1 2018 | $53,000 | -13.1% | 7,371 | -2.6% | 0.00% | – |
Q4 2017 | $61,000 | +41.9% | 7,570 | +86.2% | 0.00% | – |
Q3 2017 | $43,000 | +26.5% | 4,065 | +32.6% | 0.00% | – |
Q2 2017 | $34,000 | – | 3,065 | +4615.4% | 0.00% | – |
Q1 2017 | $0 | – | 65 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |